Department of Family and Community Medicine, McGovern Medical School, The University of Texas Health Science Center, Houston.
Department of Epidemiology, School of Public Health, The University of Texas Health Science Center, Houston.
JAMA Intern Med. 2024 Jun 1;184(6):631-640. doi: 10.1001/jamainternmed.2024.0276.
Women with adverse pregnancy outcomes, such as preterm delivery or preeclampsia, have higher future risks of cardiometabolic disorders; however, little is known about their long-term mortality risks. A better understanding of such risks is needed to facilitate early identification of high-risk women and preventive actions.
To determine long-term mortality risks associated with 5 major adverse pregnancy outcomes in a large population-based cohort of women.
DESIGN, SETTING, AND PARTICIPANTS: This national cohort study in Sweden used the Swedish Medical Birth Register, containing prenatal and birth information for nearly all deliveries in Sweden since 1973, to identify women who had a singleton delivery during 1973 to 2015. All 2 195 667 such women with information for pregnancy duration and infant birth weight were included in the study. Data were analyzed from March to September 2023.
Adverse pregnancy outcomes (preterm delivery, small for gestational age, preeclampsia, other hypertensive disorders, and gestational diabetes), identified from nationwide birth records.
All-cause and cause-specific mortality through December 31, 2018. Cox regression was used to compute hazard ratios (HRs) for mortality associated with specific adverse pregnancy outcomes, adjusted for other maternal factors. Cosibling analyses assessed for confounding by shared familial (genetic or environmental) factors.
In 56 million person-years of follow-up to a median (IQR) age of 52 (42-61) years, 88 055 women (4%) died (median [IQR] age at death, 59 [50-67] years). All 5 adverse pregnancy outcomes were independently associated with increased mortality. Across the entire follow-up (≤46 years after delivery), adjusted HRs for all-cause mortality associated with specific adverse pregnancy outcomes were as follows: gestational diabetes, 1.52 (95% CI, 1.46-1.58); preterm delivery, 1.41 (95% CI, 1.37-1.44); small for gestational age, 1.30 (95% CI, 1.28-1.32); other hypertensive disorders, 1.27 (95% CI, 1.19-1.37); and preeclampsia, 1.13 (95% CI, 1.10-1.16). All HRs remained significantly elevated even 30 to 46 years after delivery. These effect sizes were only partially (0%-45%) reduced after controlling for shared familial factors in cosibling analyses. Women who experienced multiple adverse pregnancy outcomes had further increases in risk. Several major causes of death were identified, including cardiovascular and respiratory disorders and diabetes.
In this large national cohort study, women who experienced any of 5 major adverse pregnancy outcomes had increased mortality risks that remained elevated more than 40 years later. Women with adverse pregnancy outcomes need early preventive evaluation and long-term follow-up for detection and treatment of chronic disorders associated with premature mortality.
患有早产或子痫前期等不良妊娠结局的女性未来患心血管代谢疾病的风险更高;然而,对于她们的长期死亡率风险知之甚少。为了便于早期识别高危女性并采取预防措施,需要更好地了解这些风险。
在一个大型基于人群的女性队列中,确定与 5 种主要不良妊娠结局相关的长期死亡率风险。
设计、地点和参与者:这项在瑞典进行的全国性队列研究利用瑞典医学出生登记处的数据,该登记处包含了自 1973 年以来瑞典几乎所有分娩的产前和分娩信息,以确定 1973 年至 2015 年间单胎分娩的女性。所有 2195667 名具有妊娠持续时间和婴儿出生体重信息的女性均纳入研究。数据于 2023 年 3 月至 9 月进行分析。
不良妊娠结局(早产、小于胎龄儿、子痫前期、其他高血压疾病和妊娠期糖尿病),从全国性的分娩记录中确定。
截至 2018 年 12 月 31 日的全因和特定原因死亡率。使用 Cox 回归计算与特定不良妊娠结局相关的死亡率的风险比(HR),并根据其他产妇因素进行调整。同胞分析评估了由共同的家族(遗传或环境)因素引起的混杂。
在中位数(IQR)年龄为 52 岁(42-61 岁)的 5600 万个人年随访中,88055 名女性(4%)死亡(死亡时的中位数年龄[IQR],59 [50-67] 岁)。所有 5 种不良妊娠结局均与死亡率升高独立相关。在整个随访期间(分娩后≤46 年),与特定不良妊娠结局相关的全因死亡率的调整后 HR 如下:妊娠期糖尿病,1.52(95%CI,1.46-1.58);早产,1.41(95%CI,1.37-1.44);小于胎龄儿,1.30(95%CI,1.28-1.32);其他高血压疾病,1.27(95%CI,1.19-1.37);子痫前期,1.13(95%CI,1.10-1.16)。即使在分娩后 30 至 46 年,所有 HR 仍显著升高。同胞分析控制了共同的家族因素后,这些效应大小仅降低了 0%-45%。经历多种不良妊娠结局的女性风险进一步增加。确定了几个主要的死亡原因,包括心血管和呼吸系统疾病以及糖尿病。
在这项大型全国性队列研究中,经历了 5 种主要不良妊娠结局之一的女性的死亡率风险增加,并且这种风险在 40 多年后仍居高不下。有不良妊娠结局的女性需要早期进行预防性评估和长期随访,以发现和治疗与过早死亡相关的慢性疾病。